烟曲霉素在防治蜜蜂孢子虫病中的应用研究进展  

Research progress on the application of fumagillin to control Nosema diseases in honeybees

作　　者：陈秀贤[1] 蔺哲广 胡福良[1] 宋伊雯[1] 郑火青[1] 

机构地区：[1]浙江大学动物科学学院,杭州310058

出　　处：《环境昆虫学报》2016年第3期648-654,共7页Journal of Environmental Entomology

基　　金：浙江省公益性技术应用研究项目(2014C32060)

摘　　要：近年来,全球性蜂群损失严重,对蜜蜂授粉农业造成巨大冲击。东方蜜蜂微孢子虫Nosema ceranae,N.ceranae在成功实现由东方蜜蜂Apis cerana Fabr.向西方蜜蜂Apis mellifera L.的宿主转移后,成为严重威胁西方蜜蜂健康的一种新的寄生虫病原,并被认为是蜂群损失的一个重要原因。烟曲霉素是一种能够有效防治蜜蜂孢子虫病的药物,但作为一种抗生素类药物,其在蜂产品中的残留问题以及对蜂群和人类健康的影响也颇受关注。本文将围绕蜜蜂孢子虫病概况、烟曲霉素在治疗蜜蜂孢子虫病以及人类疾病中的应用及其潜在的问题等进行综述,以期为我国养蜂生产中蜜蜂孢子虫病的防治以及烟曲霉素在相关领域中的应用提供参考。The serious losses of honeybee colonies are globally weakening bee-dependent pollination agriculture in recent years. After a successful host switch from Asian bees（ Apis cerana Fabr.） to western bees（ Apis mellifera L.）,Nosema ceranae has become a new fatal parasite to western honeybees and is suspected as a major culprit for the colony losses. Fumagilin is an effective drug against Nosema diseases.As an antibiotic drug,however,the residual problem of fumagillin in bee products and its impact on the health of honeybees and human beings are highly considered. This review summaries a general introduction about Nosema diseases in bees,the use of fumagillin in treating diseases both in human and honeybees and its potential problems. The aim is to provide references for controlling honeybee microsporidian diseases as well as applying fumagillin in related fields in China.

关 键 词：烟曲霉素 蜜蜂孢子虫病 东方蜜蜂微孢子虫 抗生素 

分 类 号：Q965.9[生物学—昆虫学] S895[农业科学—特种经济动物饲养]